Dominique Salmon Ceron

Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results

José M. Gatell, Dominique Salmon Ceron, Adriano Lazzarin et al. · Clinical Infectious Diseases · 2007 · 142 citations · Full text

Increased Risk of Serious Bacterial Infections Due to Maternal Immunosuppression in HIV-Exposed Uninfected Infants in a European Country

Clément Taron-Brocard, Jérôme Le Chenadec, Albert Faye et al. · Clinical Infectious Diseases · 2014 · 85 citations · Full text

Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study

Dominique Salmon Ceron, S. Bartier, Charlotte Hautefort et al. · Journal of Infection · 2020 · 72 citations · Full text

Allergy, Nasal Obstruction, Covid-19 Pandemic +6

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Karine Lacombe, Hélène Fontaine, Catherine Dhiver et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 34 citations · Full text

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection

Sara Lodi, Marina B. Klein, Andri Rauch et al. · Journal of the International AIDS Society · 2022 · 14 citations · Full text